(Q40524835)

21 September 2017

1 reference

title

Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy (English)

1 reference

21 September 2017

S O'Reilly

1

1 reference

21 September 2017

M J Kennedy

series ordinal

2

1 reference

21 September 2017

E K Rowinsky

series ordinal

3

1 reference

21 September 2017

R C Donehower

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Breast Cancer Research and Treatment

21 September 2017

1 reference

21 September 2017

33

1 reference

21 September 2017

1

1 reference

21 September 2017

1-17

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00666066

21 September 2017

0 references

cites work

Mode of action of chemotherapy in vivo on human acute leukemia—II. Vincristine

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00666066

Studies of the differentiation properties of camptothecin in the human leukaemic cells K562

21 January 2018

1 reference

12 December 2020

The synthesis of Navelbine prototype of a new series of vinblastine derivatives

1 reference

12 December 2020

Phase-II study of Navelbine in advanced breast cancer

1 reference

12 December 2020

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

12 December 2020

Overview of new treatments for breast cancer

1 reference

12 December 2020

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence

1 reference

12 December 2020

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin

1 reference

12 December 2020

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

1 reference

12 December 2020

A Review of the Antitumour Activity of Vinorelbine in Breast Cancer

1 reference

12 December 2020

Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy

1 reference

12 December 2020

The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics

1 reference

12 December 2020

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

1 reference

12 December 2020

Nonlinear pharmacokinetics of CPT-11 in rats

1 reference

12 December 2020

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

1 reference

12 December 2020

Navelbine: a new step in cancer therapy?

1 reference

12 December 2020

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1 reference

12 December 2020

Specific alterations in the biological activities of C-20'-modified vinblastine congeners

1 reference

12 December 2020

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study

1 reference

12 December 2020

A mechanism of cellular resistance to drugs that interfere with microtubule assembly

1 reference

12 December 2020

Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody

1 reference

12 December 2020

Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro

1 reference

12 December 2020

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

1 reference

12 December 2020

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

12 December 2020

The current status of camptothecin analogues as antitumor agents

1 reference

12 December 2020

New vinca alkaloids and related compounds

1 reference

12 December 2020

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

12 December 2020

The Current and Future Place of Vinorelbine in Cancer Therapy

1 reference

12 December 2020

Pharmacokinetics and metabolism of Navelbine

1 reference

12 December 2020

Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer

1 reference

12 December 2020

Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma

1 reference

12 December 2020

Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

1 reference

12 December 2020

Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung

1 reference

12 December 2020

The effects of camptothecin on mammalian DNA

1 reference

12 December 2020

Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.

1 reference

12 December 2020

Experimental antitumor activity of Navelbine

1 reference

12 December 2020

Safety and tolerance of Navelbine in phase I-II clinical studies

1 reference

12 December 2020

Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood

1 reference

12 December 2020

Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

1 reference

12 December 2020

Treatment of malignant melanoma with camptothecin (NSC-100880)

1 reference

12 December 2020

Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.

1 reference

12 December 2020

Definition of three classes of binding sites in isolated microtubule crystals

1 reference

12 December 2020

Effects of camptothecin on the breakage and repair of DNA during the cell cycle

1 reference

12 December 2020

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

1 reference

12 December 2020

THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

1 reference

12 December 2020

Clinical trials with the topoisomerase I inhibitors

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer

1 reference

12 December 2020

Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.

1 reference

12 December 2020

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

1 reference

12 December 2020

The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B

1 reference

12 December 2020

Phase II study of vinorelbine by oral route (in a hard gelatine capsule) for metastatic breast cancer patients. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666066

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference